Vaccine against pneumonia caused by Streptococcus pneumoniae, based on a hybrid protein

Vaccine developed by methods of molecular biology, genetic engineering and recombinant DNA

   Vaccine developed by methods of molecular biology, genetic engineering and recombinant DNA. Highly effective vaccine are based on hybrid proteins (do not contain the viruses themselves). Proposed vaccine are characterized by greater efficiency and safety compared to the commercial vaccines, as well as a wider range of applications. Have no analogues in the world.
     The invention is included in the «Prospective inventions» base, Patent № RU 2510281
   The invention received a prize at the international exhibition of inventions and innovative technologies «Archimedes»

Fill in your application

Please, fill in your application
Do you want to get a specialist consultation?